Literature DB >> 15045191

[Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system].

P G Hammerer1, H Augustin, J Blonski, M Graefen, A Haese, A Erbersdobler, F Daghofer, H Huland.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15045191     DOI： 10.1007/s00120-004-0531-8

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  13 in total

1.  Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma.

Authors:  Stefan Conrad; Markus Graefen; Uwe Pichlmeier; Rolf-Peter Henke; Andreas Erbersdobler; Peter G Hammerer; Hartwig Huland
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

2.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

3.  Transrectal prostate ultrasonography: variability of interpretation.

Authors:  M I Resnick; J A Smith; P T Scardino; M J Egger; A Hernandez; S C Rose
Journal:  J Urol       Date:  1997-09       Impact factor: 7.450

Review 4.  Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.

Authors:  H B Carter; J Sauvageot; P C Walsh; J I Epstein
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

5.  Stage migration in clinically localized prostate cancer.

Authors:  J Noldus; M Graefen; A Haese; R P Henke; P Hammerer; H Huland
Journal:  Eur Urol       Date:  2000-07       Impact factor: 20.096

6.  Patients with abnormal ultrasound of the prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors.

Authors:  R Tiguert; E L Gheiler; D J Grignon; P J Littrup; W Sakr; J E Pontes; D P Wood
Journal:  J Urol       Date:  2000-05       Impact factor: 7.450

7.  Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?

Authors:  Makoto Ohori; Michael W Kattan; Takuji Utsunomiya; Kazuho Suyama; Peter T Scardino; Thomas M Wheeler
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

8.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

9.  Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.

Authors:  W H Pinover; A Hanlon; W R Lee; E J Kaplan; G E Hanks
Journal:  Cancer       Date:  1996-04-01       Impact factor: 6.860

10.  Prostate-specific antigen detected prostate cancer: pathological characteristics of ultrasound visible versus ultrasound invisible tumors.

Authors:  J K Ferguson; D G Bostwick; V Suman; H Zincke; J E Oesterling
Journal:  Eur Urol       Date:  1995       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.